As shown in multiple in vitro and in vivo models, CaSR and its downstream signalling play a crucial and differential role in various leukaemia types, contributing to disease progression and self-renewal capabilities of LSC in AML. This evidence concerns the gene CASR and acute myeloid leukemia.